A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89

Summary

To assess the safety of single oral doses of 1592U89 (abacavir succinate, ABC) administered to HIV-positive individuals. To determine the pharmacokinetics of 1592U89 after single oral doses. To determine the effects of food on the bioavailability of 1592U89.

Timeline

Start

1994-07

Primary completion

—

Completion

—

Drugs

Indications